Explore our latest insights and research on clinical trials
From grocery baskets to wellness spend, GLP-1s are changing consumer habits. What brands and patients should know.
Large-scale analyses associate GLP-1 therapy with improved survival in type 2 diabetes and obstructive sleep apnea. Mechanisms and clinical takeaways.
Observational analyses suggest lower risk of certain cancers with GLP-1 therapy compared with insulin in type 2 diabetes. Caveats and context.
In diabetics with chronic kidney disease, semaglutide has shown reductions in cardiac deaths and delayed CKD progression. What to monitor.
Late-stage trials suggest tirzepatide can significantly improve obstructive sleep apnea metrics. How to identify candidates and measure benefit.
